BioCentury
ARTICLE | Regulation

TREATing FDA

Sen. Hagan's TREAT bill would create a progressive approval pathway at FDA

November 14, 2011 8:00 AM UTC

Legislation drafted by Sen. Kay Hagan (D-N.C.) in collaboration with BIOseeks to create an FDAprogressive approval pathway that could expand accelerated approval to include virtually all new molecular entities.

The Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act also would give FDA authority to approve compounds based on approvals in Europe and some other countries...